Ionis to present at 44th Annual J.P. Morgan Healthcare Conference

Audio By Carbonatix

CARLSBAD, Calif.--(BUSINESS WIRE)--Jan 6, 2026--

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 44 th Annual J.P. Morgan Healthcare Conference at 8:15 a.m. PT on Tuesday, January 13, 2026.

A live webcast of the presentation can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events. A replay will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals, Inc.

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260106304033/en/

CONTACT: Ionis Pharmaceuticals Investor Contact:

D. Wade Walke, Ph.D. –[email protected]–760-603-2331Ionis Pharmaceuticals Media Contact:

Hayley Soffer –[email protected]– 760-603-4679

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH GENETICS RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY

SOURCE: Ionis Pharmaceuticals, Inc.

Copyright Business Wire 2026.

PUB: 01/06/2026 07:05 AM/DISC: 01/06/2026 07:05 AM

http://www.businesswire.com/news/home/20260106304033/en